Eisler Capital (UK)’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$22.9M Buy
791,705
+30,229
+4% +$882K 0.11% 177
2024
Q2
$21.3M Buy
761,476
+232,179
+44% +$6.39M 0.14% 152
2024
Q1
$14.7M Buy
529,297
+190,955
+56% +$5.3M 0.12% 160
2023
Q4
$9.74M Buy
338,342
+216,036
+177% +$6.53M 0.08% 206
2023
Q3
$4.06M Buy
+122,306
New +$4.33M 0.03% 296

Other funds holding PFE

Eisler Capital (UK)'s PFE Position: Q3 2024 in Review

Eisler Capital (UK) increased its Pfizer (PFE) stake by 25% in Q3 2024, buying an estimated $164K and bringing the position to 27,854 shares worth $806K. The position accounts for ﹤0.01% of the portfolio, ranked #504.

Eisler Capital (UK) first reported a position in PFE in Q3 2023 and has held it in 5 quarters since. The position peaked at $3.5M in Q4 2023. 2,910 funds tracked by Wall St. Rank hold PFE as of Q3 2024.

  • Eisler Capital (UK) held 27,854 shares of Pfizer worth $806K as of Q3 2024.
  • Eisler Capital (UK) bought 5,629 Pfizer shares in Q3 2024, an estimated $164K.
  • Pfizer made up ﹤0.01% of Eisler Capital (UK)'s portfolio in Q3 2024, its #504 holding.
  • Eisler Capital (UK) first reported a position in Pfizer in Q3 2023 and has held it in 5 quarters since.
  • Eisler Capital (UK)'s Pfizer position peaked at $3.5M in Q4 2023.
  • 2,910 funds tracked by Wall St. Rank held Pfizer as of Q3 2024.

Based on Eisler Capital (UK)'s 13F filing for Q3 2024, filed 14 Nov 2024.